After years of setbacks for the antibiotic ceftobiprole, Basilea Pharmaceutica’s antifungal isavuconazole is now on the cusp of winning FDA approval. And Basilea thinks it and partner Astellas Pharma have a potential blockbuster on their hands.

…read more

Source: Basilea eyes blockbuster sales after antifungal gets FDA panel OK


0 No comments